IU School of Medicine researchers have developed an “optic nerve on a chip," which models retinal ganglion cells derived from human pluripotent stem cells. The 3D chip allows the team to separate these cells into specific channels to pinpoint where damage from glaucoma occurs.
September 17, 2025
Researcher studies neuron link between impulsivity and alcohol use disorder
Nearly 28.9 million people over the age of 12 in the U.S. lived with an alcohol use disorder in the past year. A postdoctoral fellow at the IU School of Medicine is investigating how specific neurons found in the brain’s prefrontal cortex may impact impulsive behaviors among those with a genetic risk for alcohol use disorder.September 11, 2025
IU co-founded startup aims to propel novel Alzheimer’s disease drugs into clinical trials
The IU School of Medicine has several programs dedicated to Alzheimer's disease research, from basic and translational science to clinical research and innovation.
August 20, 2025
Candice Brown joined the IU School of Medicine to grow the school’s neurovascular basic science and clinical research programs.
August 14, 2025
New national center at IU to develop stem cell brain models to better understand Alzheimer’s disease
Indiana University is leading the way nationally as the home to one of only two centers in the United States dedicated to developing stem-cell-based models of the human brain to better understand the underlying causes of Alzheimer's disease and dementias.
July 31, 2025
Two IU leaders in Alzheimer's disease research receive international acclaim
IU Alzheimer's disease researchers Bruce Lamb and Donna Wilcock received prestigious awards at the Alzheimer’s Association International Conference, recognizing them as leaders and mentors in the field.July 29, 2025
IU School of Medicine researchers receive top awards at international Alzheimer’s disease conference
Research leaders at the IU School of Medicine will receive two of the top six awards given out by the Alzheimer’s Association at its annual international conference.July 28, 2025
Researchers bring promising Alzheimer’s drug target closer to potential clinical trials
IU School of Medicine researchers aim to develop a new treatment for neurodegeneration by targeting an immune cell-specific gene associated with Alzheimer's disease.
July 14, 2025
IU-led Alzheimer’s drug discovery center moves forward with promising new therapeutic targets
IU School of Medicine researchers have identified a portfolio of novel drug targets that may accelerate promising treatments for people living with Alzheimer’s disease.
July 14, 2025
Timothy Richardson is a research professor of medicine at the IU School of Medicine and helps lead the TREAT-AD drug discovery center.
June 16, 2025
The blood test is for adults 55 and older who exhibit symptoms and is the first of its kind, with more than 90% effectiveness.
June 09, 2025
Researchers investigating how gut bacteria impacts Alzheimer’s disease progression
A team of researchers at the Indiana University School of Medicine is investigating a bacterial connection between the gut microbiome and microglia actions in Alzheimer’s disease. Growing evidence has shown that the gut can impact a person’s neurological health and potentially the progression of neurodegeneration.
May 28, 2025